$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-21-000042 Size: 5 KB 网页链接
$Recro制药(REPH)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-140895 Act: 34 Size: 59 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000849 Size: 5 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000850 Size: 5 KB 网页链接
$Recro制药(REPH)$ 内部交易: 2020-12-18,10% Owner,SCP Vitalife Partners II LP ,卖出,18587普通股, $3.03
$Recro制药(REPH)$ 内部交易: 2020-12-18,10% Owner,SCP Vitalife Partners (Israel) ,卖出,6208普通股, $3.03
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000845 Size: 5 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000846 Size: 5 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-20-323285 Act: 34 Size: 383 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000836 Size: 8 KB 网页链接